File(s) not publicly available
Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: Results of a Phase I study
Version 2 2024-06-02, 23:22
Version 1 2023-11-02, 05:13
journal contribution
posted on 2024-06-02, 23:22 authored by HM Prince, D Rischin, M Quinn, D Allen, R Planner, D Neesham, Priscilla GatesPriscilla Gates, J DavisonRepetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: Results of a Phase I study
History
Journal
GYNECOLOGIC ONCOLOGYVolume
81Pagination
216-224Location
United StatesPublisher DOI
ISSN
0090-8258eISSN
1095-6859Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalIssue
2Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCEUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineOncologyObstetrics & Gynecologyovarian cancerhigh-dose therapytopotecanpaclitaxelcarboplatinCOLONY-STIMULATING FACTORGYNECOLOGIC-ONCOLOGY-GROUPCHEMOTHERAPY REGIMENSSEQUENTIAL CYCLESTREATED PATIENTSMULTIPLE CYCLESRENAL-FUNCTIONMARROW RESCUESOLID TUMORSSTAGE-III
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC